Venetoclax Is Effective in Small Cell Lung Cancers With High BCL-2 Expression

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-17-1606
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

MARCH8 Is Associated With Poor Prognosis in Non-Small Cell Lung Cancers Patients

Oncotarget
Oncology
2017English

Simultaneous Evaluation of Viability and BCL-2 in Small-Cell Lung Cancer

Cytometry Part A
Forensic MedicinePathologyHistologyCell Biology
2008English

Prognostic Value of BCL-2 Expression in Patients With Non-Small-Cell Lung Cancer: A Meta-Analysis and Systemic Review

OncoTargets and Therapy
OncologyPharmacology
2015English

Expression Profile of BCL-2, BCL-XL, and McL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models

Molecular Cancer Therapeutics
Cancer ResearchOncology
2016English

The Combination of Venetoclax and Ibrutinib Is Effective in Relapsed/Refractory T-Prolymphocytic Leukemia and Influences BCL-2-Family Member Dependencies

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

PD‑L1 Expression Is Associated With Advanced Non‑small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2016English

P084 Musashi-2 Expression Is an Prognostic Factor for Postoperative Survival in Patients With Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Downregulation of KPNA2 in Non-Small-Cell Lung Cancer Is Associated With Oct4 Expression

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2013English

P1.03-12 PD-L1 Expression Is Predominant in CD68+ Tumor-Associated Macrophages in Stage I-Iii Non-Small Cell Lung Cancers

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy